Regen BioPharma Inc (RGBP): Total Assets
$274.6K
As of 2025-09-30
$287.6K
As of 2026-06-30
-21.1%
3-year compound annual growth
+17.4%
5-year compound annual growth
+2.2%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | $274.6K | +70.5% | 2025-12-30, Balance as of period end |
| 2024-09-30 | $161.1K | -54.4% | 2025-12-30, Balance as of period end |
| 2023-09-30 | $353.6K | -36.7% | 2025-05-13, Balance as of period end |
| 2022-09-30 | $559.0K | -53.9% | 2023-11-20, Balance as of period end |
| 2021-09-30 | $1.21M | +883.9% | 2022-11-15, Balance as of period end |
| 2020-09-30 | $123.2K | +24.3% | 2021-12-22, Balance as of period end |
| 2019-09-30 | $99.1K | -52.6% | 2021-08-04, Balance as of period end |
| 2018-09-30 | $209.0K | -77.9% | 2021-06-21, Balance as of period end |
| 2017-09-30 | $944.2K | +195.7% | 2018-12-27, Balance as of period end |
| 2016-09-30 | $319.4K | +44.9% | 2016-12-21, Balance as of period end |
| 2015-09-30 | $220.5K | n/m | 2016-12-21, Balance as of period end |
| 2014-09-30 | $10.7K | -90.8% | 2017-04-28, Balance as of period end |
| 2013-09-30 | $115.9K | n/a | 2014-12-18, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Regen BioPharma Inc (RGBP) | 2025-09-30 | $274.6K | +70.5% |
| Clene Inc. (CLNN) | 2025-12-31 | $18.13M | -33.7% |
| Abvc Biopharma, Inc. (ABVC) | 2025-12-31 | $21.06M | +179.3% |
| Vyome Holdings, Inc (HIND) | 2025-12-31 | $6.50M | +370.3% |
| Allarity Therapeutics, Inc. (ALLR) | 2025-12-31 | $18.26M | -19.4% |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | $17.74M | -49.3% |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | $697.5K | -30.7% |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | $9.51M | +4.3% |
| Medicinova Inc (MNOV) | 2025-12-31 | $45.60M | -18.4% |
Compare RGBP, CLNN, ABVC, HIND side by side · Screen every company in Pharmaceutical Preparations ↗